CLINICAL TRIALS PROFILE FOR MAGNESIUM SULFATE
✉ Email this page to a colleague
All Clinical Trials for MAGNESIUM SULFATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002146 ↗ | Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study | Completed | Astra USA | Phase 4 | 1969-12-31 | To determine whether acute ionized hypomagnesemia and hypocalcemia immediately following foscarnet infusions can be lessened or eliminated by prior infusion of magnesium sulfate. To determine whether reductions in ionized magnesium, ionized calcium, and parathyroid hormone levels following foscarnet infusions are lessened by preinfusion of magnesium sulfate. To evaluate the safety of intravenous magnesium sulfate prior to foscarnet infusion by monitoring blood pressure, heart rate, and heart rhythm. To characterize the effect of magnesium sulfate on foscarnet blood levels and urinary excretion of calcium, magnesium, phosphate, and foscarnet. |
| NCT00004399 ↗ | Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia | Completed | University of Utah | N/A | 1995-09-01 | OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia. |
| NCT00004399 ↗ | Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia | Completed | FDA Office of Orphan Products Development | N/A | 1995-09-01 | OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia. |
| NCT00004730 ↗ | Magnesium Sulfate For Brain Injury | Completed | University of Washington | Phase 3 | 1998-08-01 | The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school. |
| NCT00007033 ↗ | Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease | Completed | Children's Hospital Medical Center, Cincinnati | N/A | 2000-10-01 | OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAGNESIUM SULFATE
Condition Name
Clinical Trial Locations for MAGNESIUM SULFATE
Trials by Country
Clinical Trial Progress for MAGNESIUM SULFATE
Clinical Trial Phase
Clinical Trial Sponsors for MAGNESIUM SULFATE
Sponsor Name
